Chronic obstructive pulmonary disease (COPD) is predicted to become the third leading cause of death and disability worldwide by 2030; with cigarette smoking (active or passive) being one of the chief cause of its occurrence. Cigarette smoke exposure has been found to result in excessive inflammation and tissue injury, which might lead to COPD, although the exact pathophysiology of the disease remains elusive. While previous studies have demonstrated the role of membranebound Toll-like receptors (TLRs) in cigarette smoke (CS)-induced inflammation, scant information is available about the role of cytosolic NOD-like receptors (NLRs) in regulating CS-mediated inflammatory responses. Thus, we investigated the role of NLRP10 and NLRP12 in regulating inflammatory responses in human alveolar type II epithelial cells (A549) and human monocytic cells (THP-1) in response to a challenge with cigarette smoke extract (CSE). We observed CSE-mediated increase in caspase-1 activity; production of IL-1β and IL-18; and expression of NLRP10 and NLRP12 in A549 and THP-1 cells. Interestingly, immunofluorescence imaging results demonstrated an increase in the membrane recruitment of NLRP10 and NLRP12 proteins in CSE-challenged A549 cells. We also observed an increase in the expression of lipid raft proteins (caveolin-1, caveolin-2, and flotillin-1) and an induction of lipid raft assembly following CSE-exposure in A549 cells. Lipid rafts are cholesterol-rich membrane microdomains well known to act as harbours for signalling molecules. Here we demonstrate the recruitment of NLRP10 and NLRP12 in lipid raft entities as well as the interaction of NLRP12 with the lipid raft protein caveolin-1 in CSE-challenged A549 cells. Furthermore, enrichment of lipid raft entities with poly-unsaturated fatty acids (PUFA) rescued A549 cells from CSE-mediated membrane recruitment of NLRP10 and NLRP12, and also from inflammatory responses and inflammasome activation. Enrichment of membrane microdomains with PUFA was able to reverse filipin (chemical agent used for disrupting lipid rafts)-mediated enhanced inflammation in CSE-challenged A549 cells. Overall, our findings unveil a novel mechanism by identifying an important role of membrane microdomains (lipid rafts) in regulating CSE-induced inflammation and NLRP10/NLRP12-dependent signalling in A549 cells.
Introduction
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality with a global disease burden of 251 million cases reported in 2016 (WHO 2017) . Cigarette smoking is one of the chief etiologic factors for COPD, which causes functional and structural alterations in the airways and alveoli thus resulting in progressive, irreversible damage to the lungs (WHO 2016) . Mounting evidence demonstrates an important role of smokingdependent inflammatory responses in the development of COPD (Shaykhiev and Crystal 2013) . However, the precise mechanisms underlying the onset and progression of COPD remains elusive (Lewis et al. 2017 ).
Pattern-recognition receptors (PRRs) such as membrane bound Toll-like receptors (TLRs) and cytosolic nucleotidebinding oligomerization domain (NOD)-like receptors (NLR),work as surveillance components of innate immunity (Fukata et al. 2009 ). While the role of TLRs in the pathogenesis of COPD has been well documented (Zuo et al. 2015) , the importance of NLR proteins in the development and advancement of COPD or smoke-mediated inflammation has not been extensively explored. NLRs are a heterogeneous class of cytosolic proteins characterized by a tripartite structure comprised of a central nucleotide-binding domain termed the NACHT domain (or NOD domain), N-terminal effector domains including PYRIN, caspase recruitment domain (CARD), or baculovirus inhibitor of apoptosis protein repeat (BIR) domains for binding downstream signalling molecules, and carboxyl-terminal leucine-rich repeat (LRR) motifs (Shaw et al. 2008) . Upon activation, either due to infection or tissue damage, some NLR family members can form an inflammasome complex which regulates caspase-1 dependent maturation and release of pro-inflammatory cytokines IL-1β and IL-18. Evidence suggests the involvement of NLR/inflammasomemediated signalling in eliciting inflammatory responses in tissues obtained from chronic smokers or patients with COPD (Faner et al. 2016; Qian et al. 2015) . However, not all the NLR proteins have been studied with regards to cigarette smoke exposure. Considering this fact, we investigated the role of NLRP10 and NLRP12 in eliciting CSE-mediated inflammatory responses. NLRP10 (also known as NOD8, PAN5, Pynod, and CLR11.1) is the only member of the NLR family that lacks an LRR domain, which is essential for detection of pathogen associated molecular patterns (PAMPs) or danger associated molecular patterns (DAMPs) (Su et al. 2013) . Therefore, it is speculated that NLRP10 might play a regulatory role in inflammatory signalling through its association with other NLR proteins. While Wang and coworkers suggested a role of NLRP12 (also known as PAN6, PYPAF7, RNO2, Monarch1 and CLR19.3) as a positive regulator of caspase-1 activation, IL-1β production, and NF-κB activation (Wang et al. 2002) . Another study demonstrated NLRP12 to be an important modulator of inflammasome-mediated production of IL-1β and IL-18 in Yersinia pestis infection using C57Bl/6 mice as a study model (Vladimer et al. 2012) . Likewise, in our study we observed a CSE-mediated increase in the expression of both NLRP10 and NLRP12 in A549 cells, which prompted us to explore the signalling mechanisms associated with these NLR family members.
Despite being cytosolic receptors, some NLRs have been shown to be recruited to the plasma membrane to activate downstream signalling (Eitel et al. 2008; Kufer et al. 2008; Lautz et al. 2012) . Membrane microdomains, referred to as lipid rafts, serve as platforms for localization of different receptors and other proteins to induce cell signalling in response to external stimulus (Barnich et al. 2005; Bodas et al. 2015; Shaw 2006) . Lipid rafts have been studied in relation to several lung pathologies and are known to play an important role in mediating cellular activation and inflammation. Dudez and co-workers found that cystic fibrosis transmembrane receptors (CFTRs) harboured in lipid raft domains mediate inflammatory responses in Madin-Darby canine kidney type I cells (Dudez et al. 2008) . Another study demonstrated a direct correlation between lipid raft CFTR expression and advancement of emphysema through increased ceramide gathering in cigarette smoke-exposed C57Bl/6 mice (Bodas et al. 2011) . A significant accumulation of ceramide in lipid rafts within the lungs of COPD patients has been reported to occur with increasing severity of emphysema (Bodas et al. 2015) . Collectively, these reports indicate that lipid rafts may play a role in regulating cellular signalling during COPD.
To understand the roles of lipid rafts, NLRP10, and NLRP12 in CSE-induced inflammation, we exposed human alveolar type II epithelial (A549) cells and human monocytic (THP-1) cells to CSE. Our results demonstrated increased expression and co-localization of NLRP10 and NLRP12 proteins in A549 and THP-1 cells. We further observed membrane recruitment of NLRP10 and NLRP12 in lipid raft entities; proximity of NLRP10 with NLRP12; and physical interaction of NLRP12 with caveolin-1 (lipid raft protein) following CSE challenge in A549 cells. To study the role of lipid rafts in CSE-mediated NLRP10/NLRP12-dependent signalling, we either enriched cell media with polyunsaturated fatty acids (PUFA) to form larger rafts or used the chemical agent filipin to disrupt lipid rafts. Interestingly, enrichment of membrane microdomains with PUFA in A549 cells diminished CSE-induced recruitment of NLRP10 and NLRP12 in the membrane fractions, caspase-1 activity; and production of IL-1β. While, depletion of membrane cholesterol (a major component of lipid rafts) by filipin resulted in exacerbated response in terms of IL-1β and CCL2 (MCP-1) production, PUFA enrichment was able to rescue filipinmediated exacerbated responses in CSE-challenged cells. Overall, our findings suggest an important role of lipid rafts in CSE-induced inflammation and NLRP10/NLRP12-dependent signalling; and may help facilitate the design of improved therapeutic strategies targeting the membrane raft assembly to manage the onset and progression of COPD.
Materials and methods

Chemicals
For A549 cell culture, F-12K medium containing L-Glutamine (Corning Inc., Corning, NY) supplemented with Fetal Bovine serum (FBS) (Corning Inc., Corning, NY) and Penicillin-Streptomycin (GE Healthcare, Logan, UT) was used. For THP-1 culture, RPMI 1640 medium (GE Healthcare, Logan, 1 3 UT) supplemented with FBS and Penicillin-Streptomycin was employed. To detect cytokine/chemokine levels in cell culture media, we used ELISA kits from R&D Systems (Minneapolis, MN) or Affymetrix (eBioscience, Santa Clara, CA). Antibodies against NLRP10, NLRP12, caveolin-1, caveolin-2, and flotillin-1 used for immunoblotting were purchased from Santa Cruz Biotechnology (Dallas, TX) 
Cell culture and treatments
Human adenocarcinoma (A549) cells (Cat No# ATCC ® CCL-185) and human leukemia monocytic cells (THP-1) (Cat No# ATCC ® TIB-202) were obtained from American Type Culture Collection (ATCC, Rockville, MD) and maintained in F-12K and RPMI 1640 medium respectively, supplemented with 10% FBS and 1%v/v Penicillin-Streptomycin. Of note, A549 cells are widely used as a model for human type II alveolar epithelial cells (AECII). Extensive studies conducted to characterize A549 cells show that the surface molecules involved in antigen presentation while in resting and stimulated conditions; and their metabolic and biochemical properties are comparable to freshly isolated human type II alveolar epithelial cells (Balis et al. 1984; Corbiere et al. 2011; Foster et al. 1998; Hawdon et al. 2010; Mortaz et al. 2017; Smith 1977) . Cells were seeded in 6-well culture plates (0.35 × 10 6 / well) or poly-l-lysine coated 8-well glass slides (3.5 × 10 4 / well) and incubated overnight at 37 °C in 5% CO 2 incubator. Cells were challenged with commercially available cigarette smoke extract (CSE; Murty Pharmaceuticals Inc., Lexington, KY) at 0.25 and 1 µg/ml concentration for 6 h. According to the manufacturer, CSE was prepared by smoking 1R3F standard research cigarettes (University of Kentucky) on a Phipps-Bird 20-channel smoking machine and stored in DMSO (Huang et al. 2015; Kispert et al. 2015; Pierson et al. 2013; Wang et al. 2014) . The stock concentration of CSE was 40 mg/ml of total particulate matter containing 6% nicotine. Cells treated with dimethyl sulfoxide (DMSO) (Cat# D8418) (Sigma-Aldrich Inc., St. Louis, MO) served as negative control for our experiments.
Lipid raft enrichment studies were performed by maintaining the cells in culture media containing low endotoxin FBS, supplemented with 15.77 ng/ml (approximately 50 µM, calculated from the average molecular weight of EPA and DHA) of polyunsaturated fatty acid from animal source (PUFA) (Cat# 47015) or 25 µM Docosahexaenoic acid (DHA) (Cat# D2534) (Sigma-Aldrich, Inc., St. Louis, MO) for 24 h followed by 6 h challenge with CSE or DMSO. The PUFA used for this study is a mixture of: methyl myristate; methyl palmitate; methyl palmitoleate; methyl stearate; methyl oleate; cis-11-octadecenoic methyl ester; methyl linoleate; methyl linolenate; methyl γ-linolenate; methyl cis-11-eicosenoate; methyl arachidonate; methyl all-cis-5, 8,11,14,17-eicosapentaenoate; cis-7,10,13,16-docosatetraenoic acid methyl ester; and cis-4,7,10,13,16,19-docosahexaenoic acid methyl. We also used saturated fatty acid (arachidic acid) at 25 µM concentration to determine its effect on CSE-induced inflammation. Enrichment with PUFA or DHA was carried out in complete media as described by Schumann et al. (2011) . Cell viability was compared when the cells were maintained in FBS-or FBS-free media containing BSA (Fatty Acid Free) complexes of PUFA, respectively. Lipid raft disruption was achieved by pre-treatment of A549 cells with 5 µg/ml Filipin (Cat# F9675) (from Streptomyces filipinensis; Sigma Aldrich, St Louis, MO) for 2 h in PUFA-enriched or control group of cells followed by a 6 h challenge with CSE or DMSO. Culture media was collected and stored at − 80 °C for determination of cytokines/chemokines, while cells were collected for western blotting and mRNA expression analysis.
ELISA
Following treatment of cells, culture media was collected to determine IL-1β (R&D Systems, Minneapolis, MN), IL-18, CCL-2 and CXCL-8 (IL-8) (eBioscience, Santa Clara, CA) production by ELISA following the manufacturer's protocol. Colorimetric detection was performed at 450 nm.
mRNA expression
Cell pellets were stored in TRIzol ® Reagent (Sigma-Aldrich, St. Louis, MO) at − 80 °C for mRNA expression analysis. To determine the expression of our genes of interest, mRNA was isolated from the cells and used to prepare cDNA for RT-PCR analysis. We used Direct-zol™ RNA Kits (Cat# R2072) (Zymo Research, Irwin, CA) for RNA isolation as per manufacturer's protocol. Using iScript cDNA Synthesis kit (Cat# 1708841) (BIO-RAD Laboratories, Hercules, CA), cDNA was prepared from 1 µg of isolated total RNA, and used to determine the expression of IL-1β, IL-18, CCL-2, and CXCL-8 using gene specific human forward and reverse primers: IL-1β (Fw-5′-CAA AGG CGG CCA GGA TAT AA-3′, Rv-5′-CTA GGG ATT GAG TCC ACA TTC AG-3′), IL-18 (Fw-5′-CCA AGG AAA TCG GCC TCT ATT-3′, Rv-5′-CAT ACC TCT AGG CTG GCT ATC T-3′), CCL-2 (Fw-5′-GGC TGA GAC TAA CCC AGA AAC-3′, Rv-5′-GAA TGA AGG TGG CTG CTA TGA-3′), and CXCL-8 (Fw-5′-CTT GGC AGC CTT CCT GAT TT-3′, Rv-5′-GGG TGG AAA GGT TTG GAG TAT G-3′), for transcriptional analysis, while Actin (Fw-5′-CCC TAG TTC CAG TTC CAA GAT G-3′, Rv-5′-GGA TTT GGA GGC AGG ATG AA-3′) was used as the internal control in q-RT PCR reaction. Relative mRNA expression of each gene was determined using 7500 Fast Real-Time PCR System (Applied Biosystems, CA).
Caspase-1 activity
Caspase-1 activity was determined using caspase-1 fluorometric kit (Cat# K110) (Bio Vision, Milpitas, CA) or CaspaseGlo ® 1 homogeneous luminescent assay (Cat# G9951) (Promega Corporation, Madison, WI) kit as per manufacturer's protocol. Change in fluorescence or luminescence (depending on the kit) was plotted as relative fluorescence units (RFU) or relative luminescence units (RLU), respectively.
Immunoblotting
For western blotting experiments, cells were lysed using Urea/CHAPS/Tris buffer (8M urea, 40 mM Tris, 40 mg CHAPS,) containing a protease inhibitor cocktail (Cat# P8340) and a phosphatase inhibitor cocktail 3 (Cat# P0044) (Sigma-Aldrich, St. Louis, MO). The total protein content was determined using the Bradford protein assay kit (Thermo Fisher, Waltham, MA) . A total of 25 µg protein from each sample was mixed with 1× Laemmeli Buffer (Bio-Rad, Hercules, CA) and resolved by SDS-PAGE and electro-blotted on PVDF membrane (Bio-Rad, Hercules, CA). Blots were incubated overnight using anti-NLRP10 (Cat#sc-50608), anti-NLRP12 (Cat#sc-390666) (Santa Cruz Biotechnology, Dallas, TX), anti-caveolin-1 (Cat#3267) (Cell Signaling, Danvers, MA), anti-flotillin-1 (Cat#sc-74566) (Santa Cruz Biotechnology, Dallas, TX), anti-caveolin-2 (Cat#8522) and anti-GAPDH (Cat#5174) (Cell Signaling, Danvers, MA). Immunostaining was performed using appropriate secondary antibody (Cell Signaling, Danvers, MA) at the dilution of 1:2000. The blots were visualized on ChemiDoc Touch Imaging System (Bio-Rad, Hercules, CA) by enhanced chemiluminescence using WesternSure PREMIUM Chemiluminescent Substrate (LI-COR, Lincoln, NE).
In silico protein-protein interaction prediction
To determine potential interactions between lipid rafts associated proteins, NLRP10 and NLRP12, we conducted in silico molecular docking studies. The 3D-NMR structures were obtained from European Protein Data Bank (PDBe) (http://www.ebi.ac.uk/pdbe/). For the proteins whose NMRor X-ray crystallograpic structure is unknown, ab initio modelling was used for the in silico structure prediction. Protein sequences of caveolin-1, caveolin-2, flotillin-1 and flotillin-2 were submitted to LOMETS (Local Meta-Threading-server) (http://zhang lab.ccmb.med.umich .edu/LOMET S/) for protein structure prediction (Wu and Zhang 2007) . Of note, protein sequences for the PYD domain of NLRP10 (3D NMR solved structure PDBe ID 2 m5v) and NLRP12 (3D NMR solved structure PDBe ID2l6a) were used for this study; as the crystal structure of this domain has been resolved and identified as a putative protein-protein interaction domain. The predicted as well as 3D-NMR structures were then used for docking through ZDOCK (http://zdock .umass med.edu/), an automated web-based docking tool. PyMol, a molecular visualization software was used for analysis of our docking results (Pierce et al. 2014; PyMOL) .
Immunofluorescence
Immunofluorescence staining was conducted using 8-chamber glass slides to perform localization studies. Slides were coated for 3 h with poly l-lysine (Sigma Aldrich, USA). Cells were seeded at the cell density of 3.5 × 10 4 /well and incubated overnight in CO 2 incubator at 37 °C. Thereafter, cells were challenged with CSE (0.25 µg/ml) or DMSO for 6 h. Lipid Rafts labelling of treated cells was performed using Vybrant ® lipid raft labelling kit (Cat# V34405; Life Technologies, Carlsbad, CA) following the manufacturer's protocol. Cells were then fixed at room temperature with 2% paraformaldehyde for 20 min and permeabilized. Cells were incubated in 10% serum which served as blocking medium, followed by overnight incubation with anti-NLRP10 and anti-NLRP12 antibodies (Santa Cruz Biotechnology, Dallas, TX). After immunostaining with primary antibody, cells were washed and subsequently incubated at room temperature in a dark humid chamber with appropriate fluorochrome-conjugated secondary antibody at 1:3000 dilution. The slides were then mounted using VECTASHIELD antifade mounting medium (Vector Laboratories, Burlingame, CA). We also conducted experiments using cell-based cholesterol labelling kit (Abcam, Cat#ab133116) to identify the distribution/level of cholesterol within the cell following vendor protocol. Leica and Olympus FluoView ® FV10i Confocal Microscope were used for the analysis.
Proximity ligation assay (PLA)
To determine the possible interaction between NLRP10 and NLRP12 following CSE challenge we performed Proximity Ligation Assay (PLA) using Duolink In Situ Red Starter Kit (Sigma Aldrich, St Louis, MO) as per the manufacturer's protocol. Briefly, 8-chamber glass slides were coated with poly l-lysine for 3 h. Cells were then seeded at a density of 3.5 × 10 4 per well and incubated overnight at 37 °C in CO 2 incubator. Cells were challenged with 0.25 µg/ml of CSE or DMSO for 6 h and then fixed using 2% paraformaldehyde for 20 min at room temperature. After permeabilization and blocking, the cells were incubated overnight with primary antibody against NLRP10 (Cat# ab105407) (Abcam, Cambridge, MA) and NLRP12 (Cat# sc-390666) (Santa Cruz Biotechnology, Dallas, TX) at 1:300 dilution at room temperature. Thereafter the cells were incubated for 1 h with PLA probe (anti-rabbit PLUS and anti-mouse MINUS) followed by addition of ligation mixture for 1 h. Cells were then incubated in amplification mixture for 1.5 h at 37 °C in dark. Samples were washed thrice and dried before mounting with antifade mounting medium. The images were acquired using Olympus FluoView FV10i Confocal Microscope.
Co-immunoprecipitation
To determine the interaction between NLRP10 and NLRP12 or lipid raft proteins, co-immunoprecipitation studies were performed using Pierce Co-Immunoprecipitation Kit (Cat# 26149; Thermo Fisher, Waltham, MA) following the manufacturer's protocol with some modifications. Approximately 5 × 10 6 , A549 cells were seeded in a T-75 flask and allowed to grow overnight at 37 °C in 5% CO 2 incubator. Cells were treated with CSE (0.25 and 1 µg/ml) or DMSO (1 µg/ml) for 6 h and lysed in IP lysis buffer. Lysate was centrifuged at 13,000 g for 10 min at 4 °C and supernatant was collected. Protein concentration in each sample was estimated with Pierce BCA Protein Assay Kit (Thermo Fisher, Waltham, MA). A total of 500 µg protein per sample in 200 µl volume was taken for immunoprecipitation. Samples were precleared using 80 µl of control agarose resin slurry. Equal volume of pre-cleared protein lysate was transferred to a fresh micro centrifuge tube and 2 µg of anti-NLRP12 antibody (Cat# sc-390666) (Santa Cruz Biotechnology, Dallas, TX) was added followed by slow end to end mixing on a rotator at 4 °C overnight. Amino link plus coupling resin was equilibrated at room temperature and washed in IP lysis buffer three times. Lysate (with antibody) was transferred to amino link plus coupling beads and incubated for slow end to end mixing on rotator at 4 °C for 4 h duration. Following incubation, beads were separated by centrifugation and washed three times. For preparing immunoblotting samples, 1× loading dye was directly added to the beads and samples were heated at 95 °C for 6-8 min. Samples were resolved by SDS-PAGE and probed with antibodies targeting anticipated binding partners of NLRP12.
Membrane extraction
Approximately 3 × 10 6 , A549 cells were seeded in T-75 flask and incubated overnight at 37 °C in CO 2 incubator. Thereafter, cells were enriched with PUFA or DHA as discussed earlier. Following 24 h of membrane enrichment, cells were treated with 0.25 µg/ml of CSE for 6 h. Membrane and cytosol proteins were extracted using Mem-PERTM Plus Membrane Protein Extraction Kit (Cat#89842) (Thermo Fisher Scientific, Meridian Road, IL) as per manufacturer's protocol. In short, cells were collected after 6 h of CSE treatment, washed with Cell Wash Solution and pelleted at 300g for 5 min. Cells were then permeabilized at 4 °C for 10 min with constant mixing. Samples were centrifuged at 16,000g for 15 min and supernatant containing cytosolic proteins was collected. Cell pellet was resuspended in membrane solubilisation buffer and incubated at 4 °C for 30 min with constant mixing. Following centrifugation at 16,000g for 15 min, supernatant containing solubilized membrane and membrane-associated proteins were transferred to a fresh tube. Immunoblotting of membrane samples was performed using equal amount of proteins and the membrane localization of NLRP10 and NLRP12 was determined.
Gene knockdown
NLRP10 and NLRP12 knockdown experiments were performed using Nlrp10-siRNA (Cat# sc61140) and Nlrp12-siRNA (Cat# sc45388) (Santa Cruz Biotechnology, Dallas, TX), while Control-siRNA was used as negative control. TransIT-X2system (Cat# MIR6000) (Mirus Bio LLC Madison, WI) was used to deliver siRNA into the cells following manufacturer's protocol. Around 0.3 × 10 6 A549 cells were seeded in 6-well plate and incubated overnight at 37 °C in CO 2 incubator. Following incubation, culture media was replaced with fresh media. To perform transfection, TransIT-X2system was mixed with siRNA for specific gene or control-siRNA in culture media. The mix was added to cells in complete culture media and incubated for 48 h in CO 2 incubator. After incubation, cells were treated with 0.25 µg/ ml of CSE or DMSO. Gene knockdown was confirmed using immunoblotting assay for NLRP10 and NLRP12 protein expression.
Cell viability MTS assay
Viability of cells was determined using Cell Titer 96 AQ ueous One Solution Cell Proliferation Assay kit (Cat# G3580) (Promega Corporation, Madison, WI). Cells (A549; 3.5 × 10 3 cells/100 µl/well in 96 well plate) were cultured in PUFA [which employed FBS-or BSA (Fatty Acid Free)-complexes as delivery vehicle] or DHA-enriched media for 24 h followed by addition of 20 µl of MTS [3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt] per well. Absorbance was measured at 490 nm after 1 h incubation at 37 °C in CO 2 incubator. A standard curve was plotted (cell number vs. absorbance) to determine the viability of cells in various culture conditions.
Isolation of lipid rafts
Lipid rafts were isolated from A549 cells using Caveolae/ Rafts Isolation Kit (Sigma-Aldrich, Cat# CS0750) as per the manufacturer's protocol. Approximately 3 × 10 6 A549 cells were seeded in T-75 flask and incubated overnight at 37 °C in CO 2 incubator. Thereafter, cells were enriched with PUFA or DHA. Following 24 h of membrane enrichment, cells were lysed in 1% Triton X-100 containing lysis buffer and equal amount of proteins were used for lipid rafts isolation. Concentration gradient ranging between 0 and 35% was prepared using OptiPrep density gradient medium to isolate lipid rafts. Samples were spun at 200,000g for 4 h using table-top ultra-centrifuge (Hitachi, CS150NX). After ultra-centrifugation process, fractions were collected, and dot blot was performed using anti-caveolin-1 (lipid raft marker) to determine localization of membrane rafts in specific fractions. The fractions found positive for lipid rafts were analysed for presence of different lipid components using lipidomic analysis.
Extraction of sphingolipids and lipidomic analysis
For lipidomic analysis, internal standards procured from Avanti Polar Lipids (Alabaster, AL) were added to the samples in 10 µl ethanol: methanol: water (7:2:1) cocktail at 250 pmol concentration each. Samples were disrupted using ultra-sonicator (30 s at room temperature), followed by overnight incubation at 48 °C. Further preparatory steps included addition of KOH (1M) solubilized in methanol, followed by a short sonication step, and thereafter incubation for 2 h at 37 °C in a shaking water bath to cleave potentially interfering glycerolipids. Samples were neutralized followed by centrifugation to collect the supernatant. The extracts were Speed Vac dried and reconstituted in starting mobile phase solvent for LC-MS/MS (Liquid Chromatography with tandem Mass Spectrometry) analysis. Samples were further sonicated for 15 s and centrifuged for 5 min to collect the clear supernatant which was then transferred to the auto injector vial for analysis. LC-MS/MS analyses were performed for sphingoid bases, sphingoid base-1-phosphates, and complex sphingolipids. Separation of compounds was carried out by reverse phase LC using a Supelco 2.1 (i.d.) × 50 mm Ascentis Express C18 column (Sigma, St. Louis, MO) and a binary solvent system at 35 °C. Prior to the injection of each sample, column was equilibrated for 0.5 min with a solvent mixture of 95% mobile phase.
Statistical Significance
Data was analysed by ordinary one-way ANOVA and expressed as mean ± SE. Experiments were conducted in triplicates and were repeated 3-4 times. All statistical calculations were performed using GraphPad Prizm 6.0. Differences were considered statistically significant at *p < 0.05 when compared with controls.
Results
CSE induces Caspase-1 activity and release of pro-inflammatory cytokines and chemokines in A549 and THP-1 cells
Production of pro-inflammatory cytokines/chemokines is the key indicator of inflammation and induction of an immune response in mammals (Jun-Ming Zhang 2007) . To determine the production of key cytokines/chemokines at transcriptional and translational levels following CSE-exposure; we conducted mRNA expression analysis and ELISA. Increased production of IL-1β, IL-18, CCL-2, and CXCL-8 was observed by ELISA in CSE-challenged A549 cells (Fig. 1b) . The mRNA results further supported CSE-mediated increase in the production of IL-1β, CCL-2 and CXCL-8 by A549 cells (Fig. 1c) . To confirm if the observed changes are not cell-specific, we conducted similar studies with THP-1 cells and found increased production of pro-inflammatory cytokines, i.e., IL-1β, IL-18, CCL-2 and CXCL-8 (Fig. 1a) . We also estimated caspase-1 activity (essential for processing pro-forms of IL-1β and IL-18 into mature forms) in both THP-1 and A549 cells following CSE-exposure. We observed a significant increase in the caspase-1 activity in CSE-challenged vs. control group (Fig. 1a, b) .
Increase in the expression and membrane recruitment of NLRP10 and NLRP12 during CSE challenge
We next sought to evaluate the expression of NLRP10 and NLRP12 in CSE-challenged A549cells. Immunoblotting results demonstrate increased expression of NLRP10 and NLRP12 proteins in CSE-challenged A549 cells as compared to DMSO controls (Fig. 2a) . Previous reports have suggested that the membrane recruitment of some NLR proteins are essential to activate downstream signalling (Eitel et al. 2008; Kufer et al. 2008; Lecine et al. 2007 ). Therefore, we assessed the expression of lipid raft proteins in our study model and observed increased expression of caveolin-1, caveolin-2 and flotillin-1 following a 6 h CSE-challenge in A549 cells (Fig. 2a) . Lipid Raft labelling experiments demonstrated increased formation of lipid raft entities in CSEchallenged A549 cells as indicated by increased staining of GM-1 (monosialotetrahexosylganglioside); widely used as a lipid raft marker (Fig. 2b) . We further conducted immunofluorescence analysis to target NLRP10 and NLRP12 and determine their cellular distribution following CSEchallenge. Our results point towards membrane recruitment of NLRP10 and NLRP12 (which are cytosolic proteins in unstimulated conditions) in CSE-exposed A549 cells (Fig. 2b) . To further substantiate our findings, we performed immunoblotting on the membrane fraction obtained from CSE-challenged A549 cells. We found increased recruitment of NLRP10 and NLRP12 proteins in the membrane fractions obtained from CSE-exposed cells as compared to the controls (DMSO) (Supplementary Fig. 1 ).
NLRP10 and NLRP12 localize in lipid raft entities following CSE-exposure
Recruitment of NLRP10 and NLRP12 proteins in the cell membranes along with increased expression of lipid raft proteins and their assembly in response to CSE-exposure, prompted us to investigate possible interaction between NLRP10, NLRP12 and lipid raft associated proteins. To explore this possibility, we first used in silico protein-protein docking server ZDOCK to predict the interactions of NLR proteins (NLRP10 and NLRP12) with lipid raft proteins (caveolin-1, caveolin-2, foltillin-1 and flotillin-2). ZDOCK accomplishes high analytical accuracy on protein-protein interactions and shows precision around more than 70% in top 1000 predictions. ZDOCK data simulated interactions between NLRP10/NLRP12 and lipid raft proteins. We did not observe any prediction about hydrophilic interaction, but observed the possibility of hydrophobic interaction between NLRP10 and caveolin-1 using in silico studies (Supplementary Table 1) . Interactions between NLRP10 and caveolin-2, flotillin-1, and flotillin-2 were also predicted by ZDOCK (Supplementary Table 1) (Fig. 3a) . Similarly, in silico studies predicted the possibility of NLRP12 interaction with caveolin-1, caveolin-2, flotillin-1 and flotillin-2 (Fig. 3b) . To validate the in silico predictions we employed immunofluorescence imaging and PLA techniques. Immunofluorescence data demonstrated significant translocation of NLRP10 and NLRP12 in the membrane rafts following a 6 h CSE-challenge in A549 cells (Fig. 4a, b) . PLA findings further proved close proximity between NLRP12 and lipid raft marker, GM-1 in CSE-challenged A549 cells as compared to the controls (Fig. 4c) . These observations were further confirmed by co-immunoprecipitation studies using anti-NLRP12. Here we observed concentration (CSE)-dependent increase in the interaction between NLRP12 and caveolin-1 in CSE-challenged A549 cells (Fig. 4d) . On the other hand, our results from the proximity ligation assay and co-immunoprecipitation studies were not able to confirm the direct physical interaction of NLRP10 with caveolin-1 in CSE-challenged cells (data not presented), which points towards the possibility of involvement of other binding partners for NLRP10 that may help in its membrane recruitment and also in its role in modulating CSE-mediated responses in vitro.
Co-localization and molecular proximity between NLRP10 & NLRP12 following CSE challenge
NLRP10 is the only member of the NLR family of proteins that lacks an LRR domain. The LRR domain functions as a protein recognition motif for sensing pathogen associated molecular patterns. We, therefore, speculated that in absence of a recognition signal motif, NLRP10 may have a crucial regulatory role during CSE-induced inflammation by regulating downstream responses possibly in conjugation with NLRP12. To test this possibility, we first performed an in silico protein docking study as described earlier and found probable interaction sites between NLRP10 and NLRP12 PYD domains (Supplementary Table 1) (Fig. 5a) . Using confocal imaging, we observed co-localization of NLRP10 and NLRP12 proteins in CSE-challenged THP-1 cells (Fig. 5b) . Furthermore, PLA results demonstrated the proximity (less than 16 nm) between NLRP10 and NLRP12 in CSE-exposed A549 cells as compared to DMSO controls (Fig. 5c ) thus strengthening our hypothesis. To confirm our results, we performed co-immunoprecipitation using anti-NLRP10 (data not presented) and anti-NLRP12 antibodies. However, we were unable to detect the direct physical interaction between these two NLR family members in CSEchallenged cells under our study conditions (Fig. 4d) .
NLRP10 regulates the production of IL-1β during CSE-challenge
To substantiate the role of NLRP10 and NLRP12 in regulating CSE-mediated inflammation (inflammasome activation) we performed siRNA-mediated knockdown experiments using siRNA-Nlrp10 or siRNA-Nlrp12 in A549 cells. The NLRP10 and NLRP12 knockdown was confirmed with the help of immunoblotting using anti-NLRP10 and anti-NLRP12, respectively (Fig. 6a i, b i) . On further investigation, we observed significantly reduced production of IL-1β by CSE-challenged siRNA-Nlrp10 transfected A549 cells as compared to CSE-challenged siRNA-Control transfected cells (Fig. 6a ii) . We also observed NLRP12 mediated reduction in IL-1β following CSE-challenge; however, the response was of much lower magnitude (Fig. 6b ii) . Our results thus point towards an important regulatory role of 
Enrichment of lipid rafts with PUFA or DHA rescues A549 cells from CSE-induced inflammation
To delineate the role of lipid rafts in CSE-mediated inflammation, we enriched the membrane rafts with PUFA or DHA and challenged them with CSE for 6 h to determine inflammatory responses. Both DHA and PUFA have been shown to modulate the membrane microdomains by affecting the membrane characteristics (Stillwell and Wassall 2003; Wassall et al. 2004 ) thereby leading to alterations in lipid raftmediated cell signalling (Chapkin et al. 2008; Kim et al. 2008a; Shaikh et al. 2009 ). We therefore, first conducted lipidomic analyses of the lipid raft fractions obtained from A549 cells cultured in PUFA-or DHA-enriched media. A significant increase in the levels of DHA, eicosenoic acid (monounsaturated fatty acid) and arachidonic acid (polyunsaturated fatty acid) was observed in the raft fractions isolated from DHA/PUFA-enriched cells vs. controls, confirming successful incorporation of DHA/PUFA in the membrane lipid rafts of the A549 cells (Fig. 7b) . Furthermore, enrichment with PUFA had no effect on the cell viability. Interestingly, we observed a significant reduction in the cell viability upon replacing endotoxin free FBS with BSA (Fatty Acid Free) in our PUFA enrichment media (Fig. 7a i) .
PUFA or DHA enrichment abrogated CSE-induced transcription and production of IL-1β, CCL-2 and CXCL-8 by A549 cells (Fig. 8a, b) . Simultaneously, we also observed a reduction in CSE-mediated caspase-1 activity in PUFA and DHA-enriched A549 cells (Fig. 8c) . Additionally, cholesterol labelling experiments revealed a significant reduction in membrane cholesterol in PUFA-enriched A549 cells compared to the control group (Supplementary Fig. 2b ). It is important to note here, that the recruitment of NLRP10 and NLRP12 in the membrane fractions from CSE-challenged PUFA-enriched A549 cells was abrogated as compared to CSE-alone challenged group ( Supplementary Fig. 1 ) which further supports our hypothesis. Overall our observations suggest that enrichment of lipid rafts with PUFA-could rescue CSE-mediated inflammation; membrane recruitment of NLRP10 and NLRP12; and inflammasome/caspase-1 activation in A549 cells.
PUFA rescues filipin-mediated exacerbated responses in CSE-challenged A549 cells
To substantiate our claim in relation to the role of lipid rafts in modulating CSE-mediated inflammation in A549 cells, we disrupted the lipid raft domains by pre-treating cells with filipin prior to CSE-challenge. Pre-treatment with filipin (5 µg/ml) exacerbated CSE-induced mRNA levels of IL-1β and CCL-2. However, no significant variation in CXCL-8 mRNA expression was observed in CSE-exposed cells with/ without filipin pre-treatment. We next enriched lipid rafts with PUFA prior to filipin treatment to observe the role of modified rafts in CSE-induced inflammation. Our findings reveal a noticeable rescue of filipin-mediated exacerbated responses by PUFA in CSE-challenged A549 cells (Fig. 9) .
Enrichment of A549 cells with saturated fatty acids is unable to rescue CSE-induced responses in A549 cells
To further strengthen our hypothesis that enrichment of membrane microdomains with PUFA rescues CSE-induced inflammation, we enriched A549 cells with saturated fatty acid (arachidic acid). Our results demonstrate that enrichment of A549 cells with arachidic acid was unable to reverse CSE-induced inflammation/inflammasome activation. Instead, we observed that enrichment of A549 cells with saturated fatty acids enhanced CSE-mediated IL-1β production. While no significant change was observed in CCL-2 or CXCL-8 production between our study groups (Supplementary Fig. 2a ).
Discussion
The NLR family of proteins are widely studied for their role in inflammasome formation and signalling. To date, 22 human NLR genes have been identified, amongst which NLRP1, NLRP3, and NLRC4 have been shown to form inflammasome complexes (Proell et al. 2008; Shaw et al. 2010 ). NLRP10 and NLRP12 are two less well characterized members of this family whose actual function during inflammation remains controversial. Furthermore, NLRP10 is the only member of this family that lacks LRR domain responsible for identification or detection of PAMPs/DAMPs in humans; thus suggesting the potential for a regulatory role of this protein in cellular signalling (Ng and Xavier 2011) .
Earlier studies performed by our group showed increased expression of NLRP10 (Kaur et al. 2018 ) and NLRP12 (unpublished work) in second-hand smoke-exposed C57Bl/6 mice. In the current study, we investigated the role of membrane microdomains in regulating NLRP10 and NLRP12 mediated responses/inflammation during CSE-exposure in human alveolar type II pulmonary epithelial (A549) and human monocytic (THP-1) cells.
Experiments revealed an increase in the production of inflammatory cytokines/chemokines (IL-1β, IL-18, CCL-2, and CXCL-8) by A549 and THP-1 cells following a 6 h CSE challenge. Increased production of IL-1β has been shown in various inflammatory diseases including COPD, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease and osteoarthritis (Ren and Torres 2009; Singh et al. 2010) . Inflammasome-mediated caspase-1 activation is responsible for the production of IL-1β, IL-18 and other inflammatory mediators (Latz et al. 2013 ). Our results demonstrate an increase in caspase-1 activity of A549 and THP-1 cells in response to CSE-challenge (Fig. 1a, b) . Furthermore, we also found increased expression of NLRP10 and NLRP12 proteins in response to 6 h CSE-challenge in A549 and THP-1 cells, as compared to controls using immunoblotting and/or immunofluorescence (Fig. 2a, b) . In fact, immunofluorescence imaging results further demonstrated membrane recruitment of NLRP10 and NLRP12 proteins in CSE-challenged A549 cells (Fig. 2b) .
Membrane localization of cytosolic NLR proteins has been reported to regulate inflammatory responses following exposure to various environmental triggers (Eitel et al. 2008; Kufer et al. 2008; Lecine et al. 2007 ). For instance, NOD2 has been shown to translocate to the membrane thereby promoting the recruitment of RIP2 in MDP (muramyl dipeptide)-treated monocytic cells (Eitel et al. 2008; Lecine et al. 2007) . Similarly, NLRP10 has been identified to act as a scaffold for the assembly of the NOD1 signalling complex in a cellular model of Shigella infection (Lautz et al. 2012 ). To our knowledge, the current study is the first to show the membrane localization of NLRP10 and NLRP12 in response to CSE challenge. Moreover, membrane localization of NLRP10 and NLRP12 proteins raise the possibility of their interaction with membrane lipids or proteins. In this respect, cholesterol and sphingolipid-rich detergent-insoluble membrane microdomains, commonly known as lipid Results are a representation of three independent experiments. Error bars represent SEM, *(p < 0.05) and **(p ≤ 0.01), as per one-way ANOVA for multiple comparisons rafts, could act as an interaction platform (Shaw 2006) . A plethora of information suggests the harbouring and translocation of various signalling molecules to these microdomains and their subsequent interaction with lipid raft proteins (caveolin-1/2 and flotillin-1/2) (Anderson et al. 1998; Bagam et al. 2017; Barak and Muchova 2013; Bavari et al. 2002; Lautz et al. 2012 ). In the current study, we observed significant increase in the expression of lipid raft proteins caveolin-1/2 and flotillin-1 following a 6 h CSE challenge in A549 cells (Fig. 2a) . In addition, lipid raft assembly (as observed by increased labelling of lipid raft marker, GM-1) was also found to be enhanced in CSE-challenged A549 cells as compared to DMSO-treated controls (Fig. 2b) .
In silico modelling studies of protein-protein interactions provided strong evidence in support of a probable interaction between NLRP10 and NLRP12 and lipid raft proteins (caveolin-1/2 and flotillin-1/2) (Fig. 3a, b, 5a ; Supplementary Table 1 ). These predictions were validated by immunofluorescence studies. Confocal Imaging showed co-localization of NLRP10 or NLRP12 proteins with lipid raft marker (GM-1) (Fig. 4a, b) . In fact, we also detected proximity between NLRP12 and lipid raft marker GM-1 in CSE-challenged A549 cells using PLA (Fig. 4c) . Moreover, co-immunoprecipitation studies confirmed the physical interaction of NLRP12 with caveolin-1 in CSE-challenged A549 cells (Fig. 4d) . Despite the evidence of a possible interaction between NLRP10 and NLRP12 obtained or ii unsaturated fatty acids detected in lipid raft fractions isolated from PUFA/DHA-enriched or control A549 cells on lipidomic analysis. Equal amount of protein were used for lipid raft purification to normalize the results. (n = 3-4/group). Results are a representation of three independent experiments. Error bars represent SEM, *p < 0.05, as per two-tailed student t test through in silico studies (Fig. 5a ) and their proximity in CSE-challenged A549 cells (Fig. 5c ), we were unable to detect any direct physical interaction between them using co-immunoprecipitation studies (Fig. 4d) . Taken together these results suggest that although NLRP10 and NLRP12 may not interact with each other directly, their proximity and co-localization in lipid rafts might be critical for cigarette smoke induced inflammation. Additionally, the formation of a multi-molecular complex involving NLRP10, NLRP12, and possibly other functional partner(s), thereby directing CSE-mediated inflammasome activation and/or inflammatory responses, cannot be ruled out.
To further illustrate the roles of NLRP10 and NLRP12 in regulating inflammatory responses during CSE-exposure, we employed a knockdown strategy. Knockdown of NLRP10 significantly abrogated CSE-induced IL-1β production by A549 cells; however, the similar response by NLRP12 knockdown cells was of much lower magnitude (Fig. 6a ii, b ii). These findings provide evidence that NLRP10 has a critical role in regulating IL-1β-mediated inflammation in response to CSE-challenge in A549 cells.
Since lipid raft-mediated downstream signalling appears to be dependent on the structure and integrity of rafts, we studied the effect of lipid raft disruption (using filipin) and enrichment (using PUFA and DHA) in CSE-mediated inflammatory responses including IL-1β production. At the molecular level, PUFA alters the clustering of lipid rafts, leading to the formation of large rafts which modifies the lateral organization of signalling molecules thereby altering their function (Kim et al. 2008b; Turk and Chapkin 2013) . DHA alters membrane fluidity, permeability, phase behaviour, fusion, and resident protein activity (Turk and Chapkin 2013) . We observed a PUFA and DHA-mediated rescue in CSE-induced caspase-1 activity and cytokine/chemokine (IL-1β, CCL-2, and CXCL-8) production by A549 cells at both transcriptional and translational level (Fig. 8) . Interestingly, immunoblotting of membrane fractions isolated from PUFA or DHA-enriched CSE-challenged A549 cells show reduced recruitment of NLRP10 and NLRP12 compared to CSEchallenged cells maintained in regular growth media (Supplemental Fig. 1) . Further, enrichment of A549 cells with arachidic acid (saturated fatty acid) was unable to provide any rescue against CSE-induced inflammation, instead we Supplementary Fig. 2a ). Enrichment with saturated fatty acid did not show any significant effect on the production of CCL-2 or CXCL-8. To validate our study model we conducted lipidomic analysis of the isolated raft fractions from PUFA/DHA-enriched and control set of cells which confirmed increase in DHA, eicosenoic acid (monounsaturated fatty acid) and arachidonic acid (polyunsaturated fatty acid) in the fractions obtained from enriched cells, thus demonstrating successful incorporation of poly-unsaturated fatty acids in the membrane microdomains (Fig. 7b) . Additionally, we did not observe any change in the viability of cells cultured in PUFA/DHA-enriched media compared to cells maintained in the recommended media (low endotoxin FBS). However, we did observe a significant decline in the viability of cells cultured with PUFA complexed with fatty acid free-BSA (No FBS), supporting the working model used for our studies (Fig. 7a) (Schumann et al. 2011) .
Filipin has been known to disrupt the lipid raft integrity by binding to and depleting cholesterol (Zaas et al. 2005) . Our results show exacerbated response in terms of transcriptional Scheme 1 Schematic representation of molecular mechanisms during CSE-induced inflammation. a In a resting stage, the NLR family proteins-NLRP10 and NLRP12; are localized in the cytosol. b Challenge with CSE induces NLRP10 and NLRP12 expression and membrane recruitment. Both NLRP10 and NLRP12 are co-localized in cholesterol enriched lipid raft domains. The proximity of these two NLR family members and their recruitment to membrane rafts appear to be essential for caspase-1 activation and production of IL-1β. The downstream events of NLR signaling also include NF-κB activation following CSE-challenge. c Enrichment of A549 with PUFA alters the clustering and assembly of lipid raft domains and abrogates recruitment of NLRP10 and NLRP12 in lipid raft entities, caspase-1 activity and IL-1β production expression of inflammatory mediators (IL-1β and CCL-2) in CSE-challenged A549 cells pre-treated with filipin compared to CSE alone-challenged cells (Fig. 9) . This further emphasizes the role of lipid rafts in CSE-mediated inflammation. However, the impact of lipid raft disruption was insignificant in PUFA-enriched A549 cells when subjected to CSEchallenge. This is not surprising as previous reports suggest that PUFA perturbs the lipid composition of membrane rafts thereby altering their function (Fan et al. 2004; Ma et al. 2004) . Raft cholesterol content was found to be lowered by 46% in the colonocytes of mice fed with n-3 PUFA-enriched diet as compared to n-6 PUFA-enriched diet (Ma et al. 2004) . Similarly, the sphingomyelin and sphingolipid content in T cells was found to be reduced by 30 and 45% respectively, in mice fed with n-3 PUFA-enriched diet (Fan et al. 2004; Ma et al. 2004) . Along similar lines we observed significantly reduced membrane cholesterol in the PUFA-enriched CSEchallenged cells compared to CSE alone-challenged cells maintained in recommended growth media ( Supplementary  Fig. 2b ). Our findings suggest that reduced cholesterol levels and overall change in the microenvironment of lipid rafts in PUFA-enriched cells, renders the rafts less susceptible to filipin-mediated disruption and rescues them during CSEchallenge (Fig. 8) . Furthermore, the alterations in raft composition during PUFA enrichment possibly regulates the recruitment of signalling molecules like NLRP10 and NLRP12 as observed in isolated membrane fractions from our study groups ( Supplementary Fig. 1 ). Our results, therefore, indicate a potential role of lipid rafts in NLRP10/NLRP12 mediating inflammation in CSE-exposed A549 cells.
In conclusion, this is one of the first reports to demonstrate the membrane localization of NLRP10 and NLRP12 proteins in response to CSE-challenge. Our experiments provide evidence for (1) increased expression of lipid rafts associated proteins, NLRP10 and NLRP12 proteins, and (2) physical interaction between NLRP12 and caveolin-1 in CSE-challenged A549 cells. Using lipid raft enrichment and disruption studies, we were also able to demonstrate the crucial role played by membrane microdomains in regulating CSE-mediated sub-cellular localization of NLRP10 and NLRP12, and inflammatory responses/inflammasome activation (Scheme 1). Future investigations will focus on identifying other interacting partners of NLRP10 and NLRP12, and modulation of these interactions affected by changes in lipid raft assembly thereby impacting inflammasome activation. Our findings will advance our understanding about the molecular mechanisms associated with cigarette smoke induced inflammation. Results from our studies will be helpful for designing improved intervention strategies specifically focusing on altering the composition/assembly of lipid rafts to combat the onset and progression of inflammatory responses due to excessive smoking or smoke induced pulmonary complications.
